We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+6.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.1B
AUM Growth
+$1.81B
(+5.1%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
8.75%
Holding
2,506
New
326
Increased
944
Reduced
921
Closed
286
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$297M |
| 2 |
CELG
Celgene Corp
CELG
|
+$277M |
| 3 |
US Bancorp
USB
|
+$190M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$154M |
| 5 |
ExxonMobil
XOM
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$259M |
| 2 |
DuPont de Nemours
DD
|
+$255M |
| 3 |
Boeing
BA
|
+$243M |
| 4 |
Altria Group
MO
|
+$234M |
| 5 |
Union Pacific
UNP
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.5% |
| 2 | Technology | 15.03% |
| 3 | Consumer Discretionary | 14.19% |
| 4 | Industrials | 12.34% |
| 5 | Consumer Staples | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Bread Financial
BFH
$4.21B
| $1.65M | ﹤0.01% |
+8,173
| New | +$1.51M |
|
1327
Watts Water Technologies
WTS
$11.5B
| $1.65M | ﹤0.01% |
21,735
-5,300
| -20% | -$378K |
|
1328
Gentex
GNTX
$4.88B
| $1.65M | ﹤0.01% |
78,776
+14,000
| +22% | +$279K |
|
1329
Okta
OKTA
$24.1B
| $1.65M | ﹤0.01% |
+64,260
| New | +$1.8M |
|
|
LADR
1330
Ladder Capital
LADR
$1.25B
| $1.64M | ﹤0.01% |
119,952
+87,202
| +266% | +$1.19M |
|
1331
Middleby
MIDD
$6.05B
| $1.64M | ﹤0.01% |
+12,115
| New | +$1.48M |
|
1332
UNIFI
UFI
$117M
| $1.64M | ﹤0.01% |
45,581
+6,200
| +16% | +$224K |
|
|
DCT
1333
DELISTED
DCT Industrial Trust Inc.
DCT
| $1.63M | ﹤0.01% |
27,742
-558
| -2% | -$33K |
|
1334
Vanda Pharmaceuticals
VNDA
$312M
| $1.63M | ﹤0.01% |
107,200
-44,100
| -29% | -$654K |
|
|
TGNA
1335
DELISTED
TEGNA Inc
TGNA
| $1.62M | ﹤0.01% |
115,111
+21,700
| +23% | +$284K |
|
1336
Insteel Industries
IIIN
$633M
| $1.62M | ﹤0.01% |
57,093
-13,800
| -19% | -$370K |
|
|
LRFC
1337
DELISTED
Logan Ridge Finance Corp
LRFC
| $1.62M | ﹤0.01% |
37,002
+7,825
| +27% | +$382K |
|
|
UNIT
1338
Uniti Group
UNIT
$2.63B
| $1.61M | ﹤0.01% |
90,631
+76,300
| +532% | +$1.26M |
|
1339
Huron Consulting
HURN
$1.82B
| $1.61M | ﹤0.01% |
39,795
-21,500
| -35% | -$824K |
|
|
MRCC
1340
DELISTED
Monroe Capital Corp
MRCC
| $1.61M | ﹤0.01% |
117,041
-32,300
| -22% | -$463K |
|
1341
Sonoco
SON
$5.76B
| $1.6M | ﹤0.01% |
30,124
-29,100
| -49% | -$1.52M |
|
1342
Spectrum Brands
SPB
$2.04B
| $1.59M | ﹤0.01% |
+14,138
| New | +$1.55M |
|
1343
Horace Mann Educators
HMN
$2.1B
| $1.59M | ﹤0.01% |
36,000
+9,600
| +36% | +$419K |
|
|
OMN
1344
DELISTED
OMNOVA Solutions Inc.
OMN
| $1.58M | ﹤0.01% |
158,490
+25,463
| +19% | +$272K |
|
|
HAWK
1345
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
| $1.58M | ﹤0.01% |
44,351
+6,500
| +17% | +$234K |
|
|
ESPR
1346
DELISTED
Esperion Therapeutics
ESPR
| $1.58M | ﹤0.01% |
24,000
+9,200
| +62% | +$495K |
|
|
ACTA
1347
DELISTED
Actua Corp
ACTA
| $1.58M | ﹤0.01% |
101,266
-400
| -0.4% | -$6.21K |
|
|
XIN
1348
DELISTED
Xinyuan Real Estate
XIN
| $1.58M | ﹤0.01% |
23,170
+5,630
| +32% | +$331K |
|
|
INOV
1349
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $1.57M | ﹤0.01% |
104,437
+74,500
| +249% | +$1.19M |
|
1350
OneSpan
OSPN
$562M
| $1.56M | ﹤0.01% |
112,557
+32,800
| +41% | +$433K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, Two Sigma Advisers held 2,506 positions worth $37.1B, up 5.1% from $35.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Two Sigma Advisers's Q4 2017 filing shows 326 new, 944 increased, 921 reduced and 286 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 381,038 shares worth $143M. The largest sale was Chevron, an estimated $259M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
- Two Sigma Advisers's largest Q4 2017 buy was Regeneron Pharmaceuticals: 381,038 shares worth $143M.
- Two Sigma Advisers added most to PG&E in Q4 2017, an estimated $297M increase.
- Two Sigma Advisers's biggest Q4 2017 reduction was Chevron, cutting an estimated $259M.
- Two Sigma Advisers fully exited DuPont de Nemours in Q4 2017, selling an estimated $255M.
- Two Sigma Advisers's ten largest holdings make up 8.7% of its $37.1B portfolio in Q4 2017.
- Two Sigma Advisers opened 326 new positions and closed 286 in Q4 2017.
- Two Sigma Advisers's portfolio value rose 5.1% quarter-over-quarter to $37.1B.
Based on Two Sigma Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.